North America is anticipated to lead the global varicella vaccines market during the forecast period. The rapid development of the region can be attributed to the easy availability of varicella live vaccines and the presence of skilled healthcare experts in the region

NEWARK, Del, June 07, 2022 (GLOBE NEWSWIRE) -- A recently published Future Market Insights report forecasts that the market for varicella vaccines is scheduled to document a 6.3% value CAGR from 2022 to 2032, reaching US$ 5.76 Billion by the end of the said period of assessment. As governments worldwide attempt to rein in prevalence of infectious diseases such as chickenpox and measles, the market for varicella vaccines is slated to enjoy a bright future. 

The number of research and development projects initiated by leading pharmaceutical manufacturers to produce vaccines with a longer life are also primary factor driving the growth of the varicella vaccines market. Additionally, increasing public awareness about the benefits of vaccination along with rising government initiatives is likely to act as a catalyst for the growth of the varicella vaccines market. 

From 2015 to 2021, the market flourished significantly, reaching US$ 2.93 Billion by the end of the said historical period. The Chickenpox segment is likely to offer remunerative opportunities for the global varicella vaccines market. Several emerging economies are making significant developments in their healthcare sector, thereby, providing lucrative opportunities to players in the market.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14843

Key Takeaways: 

• Global varicella vaccines market to surpass US$ 3 Billion in value by 2022-end 
• By application, chickenpox immunization is expected to record a 7.1% CAGR until 2032  
• By product, monovalent vaccines contributed 73.2% of the total market value in 2021  
• North America to be the fastest growing market, registering a 6.7% value CAGR 
• South Asia to be the most opportunistic market, accumulating a market value of US$ 320 Million by 2032 
• China to be a key contributor in the East Asian market, growing at a 5.9% CAGR 

Competitive Landscape

Eminent players in the global varicella vaccines market include Bio-Med Pvt. Limited, Pfizer Inc., Emcure Pharmaceuticals Limited, Merck & Co Inc., Sanofi, and Novo Medi Sciences among others. Recent key developments among players include: 

• In January 2022 - Pfizer Inc. and BioNTech SE announced a new research, development, and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV) a debilitating, disfiguring, and painful disease that impacts about one in three people in the United States during their lifetime. This is the third collaboration between Pfizer and BioNTech in the infectious diseases field. 
• In July 2021 - GC LabCell and GC Cell announced merger agreement to combine in an all-stock transaction. The transaction brings together two iconic South Korean biopharmaceutical companies, highly complementary portfolios with a robust broad cell therapy R&D pipeline and cutting-edge manufacturing capabilities to accelerate growth and enhance value creation.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global varicella vaccines market presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032. 
The study reveals essential insights on the basis of product (monovalent, combination) by application (chickenpox immunization, herpes zoster immunization, mumps, measles and rubella & varicella (MMRV) immunization) and by end user (hospitals, clinics and others), across seven major regions (North America, Europe, South Asia, East Asia, Oceania, Middle East & Africa, and Latin America)

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14843

Key Segments Covered in the Varicella Vaccines Industry Survey
Varicella Vaccine Market by Product:

• Monovalent Varicella Vaccines
• Combination Varicella Vaccines

Varicella Vaccine Market by Application:

• Varicella Vaccines for Chickenpox Immunization
• Varicella Vaccines for Herpes Zoster Immunization
• Varicella Vaccines for Mumps, measles, rubella & varicella (MMRV) Immunization
  
  

Varicella Vaccine Market by End User:

• Varicella Vaccines for Hospitals
• Varicella Vaccines for Clinics
• Varicella Vaccines for Other End Users
  
  

Varicella Vaccine Market by Region:

• North America Varicella Vaccines Market
• Europe Varicella Vaccines Market
• South Asia Varicella Vaccines Market
• East Asia Varicella Vaccines Market
• Oceania Varicella Vaccines Market
• Middle East & Africa Varicella Vaccines Market
• Latin America Varicella Vaccines Market
  
  

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Bn) Analysis By Product, 2017-2021

    5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product, 2022-2032

        5.3.1. Monovalent Vaccine

        5.3.2. Combination Vaccine

    5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product, 2022-2032

6. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2017-2021

    6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2022-2032

        6.3.1. Chickenpox Immunization

        6.3.2. Herpes Zoster Immunization

        6.3.3. Mumps, Measles, Rubella, and VaricellaBImmunization

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032

Get detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14843

Have a Look at Related Research Reports of Healthcare

Cosmetic Implants Market Size: The global cosmetic Implants market garnered US$ 9.6 Billion in 2021, and is likely to exhibit a Y-o-Y increase of 6.2% to be valued at US$ 10.2 Billion in 2022.

Novel Drug Delivery Systems In Cancer Therapy Market Share: The novel drug delivery systems in the cancer therapy market are anticipated to have a thriving CAGR of 19.6% during the period of 2022-2032.

Neuroendoscopy Devices Market Forecast: The neuroendoscopy devices market is anticipated to have an effective CAGR of 7.6% during the period of 2022-2032.

Electrosurgery Devices Market Trends: The electrosurgery devices market is expected to strengthen its hold on the global market at a strong CAGR of 4.4% between 2022 and 2032.

Diabetic Retinopathy Market Analysis: The diabetic retinopathy market is likely to grow with an estimated CAGR of 5.8% from 2022 to 2032. The diabetic retinopathy market share was worth US$ 8.4 Bn in 2022.

Healthcare Biometrics Market Growth: The healthcare biometrics market is anticipated to grow with a CAGR of 18.1% from 2022 to 2032. The healthcare biometrics market share is likely to boost up to US$ 3.4 Bn in 2022.

Hemophilia Treatment Market Forecast: Demand for hemophilia treatment is projected to rise at 4.8% CAGR during the forecast period, surpassing a valuation of US$ 17.92 Bn by the end of 2032.

Cell Culture Market Demand: The global cell culture market size touched a valuation of US$ 22 Bn in 2021 and is likely to reach US$ 43 Bn in 2026.

In Vitro Fertilization Market Outlook: The global in vitro fertilization (IVF) market size is projected to grow at a healthy CAGR of 9.0% during the forecast period between 2022 and 2032, reaching around US$ 1.6 Bn by 2032.

Diabetic Shoes Market Scenario: The global diabetic shoes market size is expected to reach a valuation of US$ 7.9 Bn in 2022 and is further projected to grow at a robust CAGR of 6.4% during the forecast period between 2022 and 2032, totaling over US$ 14.9 Bn by 2032.

About Us    
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.  

Contact: 
Future Market Insights Inc.   
Christiana Corporate, 200 Continental Drive, 
Suite 401, Newark, Delaware - 19713, USA   
T: +1-845-579-5705   
Report: https://www.futuremarketinsights.com/reports/varicella-vaccines-market
For Sales Enquiries: sales@futuremarketinsights.com    
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.